289 PGV-001: a phase 1 trial of a personalized neoantigen peptide vaccine for the treatment of malignancies in the adjuvant setting by Nina Bhardwaj, Marshall Posner, Philip Friedlander, John Mandeli, Sacha Gnjatic, Eric Schadt, Samir Parekh, Julia Kodysh, Alex Rubinsteyn, John Finnigan, Ana Blazquez, Mansi Saxena, Marcia Meseck, Daniela Delbeau, Matthew Galsky, Deborah Doroshow, Brett Miles, Krysztof Misiukiewicz, Hanna Irie, Amy Tiersten, Andrea Wolf, Jeffrey Hammerbacher, Michael Donovan, Rachel Brody